Tokinolide B
CAS: 112966-16-2
Ref. 3D-MEA96616
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar | ||
| 25mg | A consultar | ||
| 50mg | A consultar |
Información del producto
- (1′S,3Z,3aS,5R,6R)-3-Butylidene-5,6,6′,7′-tetrahydro-5-propylspiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione
- (3'Z)-(3S,8R,3a'S,6'R)-3,3a':8,6'-Diligustilide
- (3′Z)-(3S,8R,3a'S,6′R)-3,3a′:8,6′-Diligustilide
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1'(3'H)-isobenzofuran]-1,3'-dione,3-butylidene-5,6,6',7'-tetrahydro-5-propyl-, [3aS-(3Z,3aa,4a,5a,6a)]-
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione, 3-butylidene-5,6,6′,7′-tetrahydro-5-propyl-, (1′S,3Z,3aS,5R,6R)-
- Spiro[3H-3a,6-ethanoisobenzofuran-4(1H),1′(3′H)-isobenzofuran]-1,3′-dione, 3-butylidene-5,6,6′,7′-tetrahydro-5-propyl-, [3aS-(3Z,3aα,4α,5α,6α)]-
Tokinolide B is a dietary supplement that is used to treat various nervous system and inflammatory diseases. This agent has been shown to inhibit the activity of the progesterone receptor, which may be due to its inhibition of fatty acid synthesis. Tokinolide B also inhibits the activity of the ligustilide-sensitive receptor, which is responsible for the transmission of nerve impulses. The biological properties of this drug have been shown in studies on humans, where it was shown to have an inhibitory effect on fatty acids and organic acids.
Propiedades químicas
Consulta técnica sobre: 3D-MEA96616 Tokinolide B
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
